Literature DB >> 19904283

Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.

Bridgette D Semple1, Thomas Kossmann, Maria Cristina Morganti-Kossmann.   

Abstract

Chemokines and their receptors have crucial roles in the trafficking of leukocytes, and are of particular interest in the context of the unique immune responses elicited in the central nervous system (CNS). The chemokine system CC ligand 2 (CCL2) with its receptor CC receptor 2 (CCR2), as well as the receptor CXCR2 and its multiple ligands CXCL1, CXCL2 and CXCL8, have been implicated in a wide range of neuropathologies, including trauma, ischemic injury and multiple sclerosis. This review aims to overview the current understanding of chemokines as mediators of leukocyte migration into the CNS under neuroinflammatory conditions. We will specifically focus on the involvement of two chemokine networks, namely CCL2/CCR2 and CXCL8/CXCR2, in promoting macrophage and neutrophil infiltration, respectively, into the lesioned parenchyma after focal traumatic brain injury. The constitutive brain expression of these chemokines and their receptors, including their recently identified roles in the modulation of neuroprotection, neurogenesis, and neurotransmission, will be discussed. In conclusion, the value of evidence obtained from the use of Ccl2- and Cxcr2-deficient mice will be reported, in the context of potential therapeutics inhibiting chemokine activity which are currently in clinical trial for various inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19904283      PMCID: PMC2949152          DOI: 10.1038/jcbfm.2009.240

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  143 in total

1.  Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration.

Authors:  Nicole Bye; Mark D Habgood; Jennifer K Callaway; Nakisa Malakooti; Ann Potter; Thomas Kossmann; M Cristina Morganti-Kossmann
Journal:  Exp Neurol       Date:  2006-12-22       Impact factor: 5.330

2.  Involvement of KC, MIP-2, and MCP-1 in leukocyte infiltration following injection of necrotic cells into the peritoneal cavity.

Authors:  Nahoko Tanimoto; Masao Terasawa; Miho Nakamura; Daisuke Kegai; Naho Aoshima; Yoshiro Kobayashi; Kisaburo Nagata
Journal:  Biochem Biophys Res Commun       Date:  2007-07-23       Impact factor: 3.575

3.  Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia.

Authors:  Yi-Ping Yan; Kurt A Sailor; Bradley T Lang; Seung-Won Park; Raghu Vemuganti; Robert J Dempsey
Journal:  J Cereb Blood Flow Metab       Date:  2006-12-27       Impact factor: 6.200

4.  Changes in blood-brain barrier permeability to large and small molecules following traumatic brain injury in mice.

Authors:  M D Habgood; N Bye; K M Dziegielewska; C J Ek; M A Lane; A Potter; C Morganti-Kossmann; N R Saunders
Journal:  Eur J Neurosci       Date:  2007-01       Impact factor: 3.386

Review 5.  CXCR2--the receptor to hit?

Authors:  Jörg Reutershan
Journal:  Drug News Perspect       Date:  2006-12

6.  The interleukin-8 (IL-8/CXCL8) receptor inhibitor reparixin improves neurological deficits and reduces long-term inflammation in permanent and transient cerebral ischemia in rats.

Authors:  Pia Villa; Sara Triulzi; Barbara Cavalieri; Rosa Di Bitondo; Riccardo Bertini; Sara Barbera; Paolo Bigini; Tiziana Mennini; Paolo Gelosa; Elena Tremoli; Luigi Sironi; Pietro Ghezzi
Journal:  Mol Med       Date:  2007 Mar-Apr       Impact factor: 6.354

7.  Chemokine ligand 2 (CCL2) induces migration and differentiation of subventricular zone cells after stroke.

Authors:  Xian Shuang Liu; Zheng Gang Zhang; Rui Lan Zhang; Sara R Gregg; Lei Wang; Toh Yier; Michael Chopp
Journal:  J Neurosci Res       Date:  2007-08-01       Impact factor: 4.164

8.  Chemokine MIP-2/CXCL2, acting on CXCR2, induces motor neuron death in primary cultures.

Authors:  Massimiliano De Paola; Pasquale Buanne; Leda Biordi; Riccardo Bertini; Pietro Ghezzi; Tiziana Mennini
Journal:  Neuroimmunomodulation       Date:  2008-04-03       Impact factor: 2.492

9.  The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions.

Authors:  Matthias Nahrendorf; Filip K Swirski; Elena Aikawa; Lars Stangenberg; Thomas Wurdinger; Jose-Luiz Figueiredo; Peter Libby; Ralph Weissleder; Mikael J Pittet
Journal:  J Exp Med       Date:  2007-11-19       Impact factor: 14.307

10.  The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease.

Authors:  Thaddeus Carlson; Mark Kroenke; Praveen Rao; Thomas E Lane; Benjamin Segal
Journal:  J Exp Med       Date:  2008-03-17       Impact factor: 14.307

View more
  180 in total

Review 1.  The role of inflammation in epilepsy.

Authors:  Annamaria Vezzani; Jacqueline French; Tamas Bartfai; Tallie Z Baram
Journal:  Nat Rev Neurol       Date:  2010-12-07       Impact factor: 42.937

Review 2.  Inflammatory responses in brain ischemia.

Authors:  Masahito Kawabori; Midori A Yenari
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

3.  Chemokine CCL2-CCR2 Signaling Induces Neuronal Cell Death via STAT3 Activation and IL-1β Production after Status Epilepticus.

Authors:  Dai-Shi Tian; Jiyun Peng; Madhuvika Murugan; Li-Jie Feng; Jun-Li Liu; Ukpong B Eyo; Li-Jun Zhou; Rochelle Mogilevsky; Wei Wang; Long-Jun Wu
Journal:  J Neurosci       Date:  2017-07-17       Impact factor: 6.167

4.  CXCL1 and CXCL2 Inhibit the Axon Outgrowth in a Time- and Cell-Type-Dependent Manner in Adult Rat Dorsal Root Ganglia Neurons.

Authors:  Antonia Teona Deftu; Ruxandra Ciorescu; Roxana-Olimpia Gheorghe; Dan Mihăilescu; Violeta Ristoiu
Journal:  Neurochem Res       Date:  2019-08-17       Impact factor: 3.996

5.  Anti-nociceptive Role of CXCL1 in a Murine Model of Peripheral Nerve Injury-induced Neuropathic Pain.

Authors:  Ling Cao; Jennifer T Malon
Journal:  Neuroscience       Date:  2018-01-06       Impact factor: 3.590

6.  Hemorrhagic shock shifts the serum cytokine profile from pro- to anti-inflammatory after experimental traumatic brain injury in mice.

Authors:  Steven L Shein; David K Shellington; Jennifer L Exo; Travis C Jackson; Stephen R Wisniewski; Edwin K Jackson; Vincent A Vagni; Hülya Bayır; Robert S B Clark; C Edward Dixon; Keri L Janesko-Feldman; Patrick M Kochanek
Journal:  J Neurotrauma       Date:  2014-08-15       Impact factor: 5.269

7.  Inflammatory markers as predictors of depression and anxiety in adolescents: Statistical model building with component-wise gradient boosting.

Authors:  Consuelo Walss-Bass; Robert Suchting; Rene L Olvera; Douglas E Williamson
Journal:  J Affect Disord       Date:  2018-03-12       Impact factor: 4.839

8.  Recruitment and retention of B cells in the central nervous system in response to alphavirus encephalomyelitis.

Authors:  Talibah U Metcalf; Victoria K Baxter; Voraphoj Nilaratanakul; Diane E Griffin
Journal:  J Virol       Date:  2012-12-19       Impact factor: 5.103

9.  CCR2 deficiency prevents neuronal dysfunction and cognitive impairments induced by cranial irradiation.

Authors:  Karim Belarbi; Timothy Jopson; Carla Arellano; John R Fike; Susanna Rosi
Journal:  Cancer Res       Date:  2012-12-13       Impact factor: 12.701

10.  Neural inflammation and the microglial response in diabetic retinopathy.

Authors:  Steven F Abcouwer
Journal:  J Ocul Biol Dis Infor       Date:  2012-04-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.